Igrat left

October 30, 2012 — MIM Software Inc. announced the availability of MIM 5.6 at the American Society for Radiation Oncology’s (ASTRO’s) 54th Annual Meeting.

MIM Maestro and MIMpacs RTTM offer tools for IGART (image-guided adapted radiation therapy), deformable QA (quality assurance), biological dose evaluation, OIS interoperability and research extendibility. These tools include:

  • Reg Reveal (patent pending) – Increased acceptance and clinical use of deformable registration has created the need for improved quality assurance of these algorithms. Reg Reveal is the first and only environment for deformable QA and reporting.
  • Biologically Effective Dose – MIM’s new BED and TCP modeling now makes multimodality dose accumulation and comparison a practical reality.
  • ART Assist – MIM has made significant enhancements to their fully customizable IGART processing and reporting tool which automatically quantifies changes to a patient over the course of radiation delivery. ART Assist makes true dose-guided adaptive radiation therapy possible.
  • MIM Extensions – By enabling users to “plug in” their own algorithms, MIM Extensions will shorten the time to take research from bench to bedside. Composed using either Java or Matlab, algorithms can be seamlessly integrated into MIM software using the elegant API.
  • OIS Compatibility – MIMpacs RT now includes enhanced OIS interoperability, allowing DICOM and DICOM RT data stored in the OIS to be simply archived in MIMpacs and restored to the OIS as needed. Using MIMpacs will also allow institutions to seamlessly leverage MIM’s image viewing and processing solution.

For more information: www.mimsoftware.com

Related Content

News | Ultrasound Women's Health

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
News | Lung Imaging

October 11, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), percutaneous image-guided microwave and ...

Time October 11, 2021
arrow
News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Women's Health

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
News | Radiation Therapy

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent ...

Time October 07, 2021
arrow
News | Women's Health

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
Subscribe Now